ARDT
Ardent Health Partners, LLC (ARDT) Business Model Analysis (2026)
Overall Score
Revenue Quality
Revenue base remains asset-light and efficient, with revenue per share at 45.21 and asset turnover at 1.21.
Gross margin is still solid at 29.96%, supporting a workable business model despite modest net margin of 1.22%.
Profitability
Operating profitability is acceptable, with operating margin at 7.54% and EBITDA margin at 6.27%.
Net margin remains thin at 1.22%, indicating limited bottom-line conversion from sales.
Return on invested capital is 9.26%, suggesting the company is earning a reasonable return on capital employed.
Cash Generation
Free cash flow generation is strong, with free cash flow yield at 19.17% and price-to-free-cash-flow at 5.22x.
Operating cash flow coverage remains healthy, supported by operating cash flow ratio of 0.52 and debt service coverage of 4.64x.
Capital expenditure remains manageable, with capex-to-revenue at 3.27% and capex coverage at 2.43x.
Balance Sheet
Liquidity is adequate, with a current ratio of 2.10 and quick ratio of 1.99.
Leverage is meaningful, with debt-to-equity at 1.68x and net debt-to-EBITDA at 3.84x.
Interest coverage of 9.74x suggests debt service is currently manageable.
Capital Allocation
The company is retaining cash, with dividend yield at 0% and dividend payout ratio at 0%.
Free cash flow per share of 2.12 and cash per share of 5.11 provide flexibility for reinvestment or deleveraging.
Stock-based compensation is low at 0.41% of revenue, limiting dilution concerns.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Ardent Health Partners, LLC. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

